Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 10 days ago Drug news

Phase III REFLECT study shows Lenvima (lenvatinib) delays in the deterioration of quality of life scores in liver cancer compared to sorafenib - Eisai.

Eisai announced a delay in the deterioration of five health-related quality of life domains that affect patients' daily lives was...

Added 1 month ago Drug news

Mundipharma acquires from Cell Act world rights to CAP7.1. a novel pro-drug of anticancer agent etoposide.

The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development,commercialization and manufacturing rights...

Added 1 month ago Drug news

Eisai files at FDA and EMA applications for lenvatinib for the treatment of hepatocellular carcinoma.

Eisai Co., Ltd. announced that it has submitted applications to the FDA and the European Medicines Agency (EMA) for its...

Search all news articles for Cancer of liver and bile duct
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

Hypogonadism

Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more.

Visit Hypogonadism

Guidelines

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

CC is the second commonest primary liver tumour worldwide, after hepatocellular carcinoma (HCC). These guidelines are intended to bring consistency...

Added 5 years ago

Erratum to: EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Fig. 3 was incomplete for BCLC stage A, and it has been corrected as per below. Patients at BCLC stage...

Added 5 years ago

Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 5 years ago

Search all guidelines for Cancer of liver and bile duct
 

Journal articles

Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?

Background and aims: Thermo-ablation by radiofrequency is recognized as a curative treatment for early-stage hepatocellular carcinoma. However, local recurrence may...

Added 1 year ago

Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Hepatocellular carcinoma (HCC) is the second commonest cause of cancer death worldwide. Rather than falling as a result of prevention...

Added 1 year ago

Search all journal articles for Cancer of liver and bile duct
 

Clinical trials

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

This study involves a course of radiation to up to 5 tumors in the participant's liver followed by systemic therapy (Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body).

Added 5 months ago

Search all clinical trials for Cancer of liver and bile duct
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.